Il mercato globale della produzione di cellule staminali è stato valutato a 12,58 miliardi nel 2022 e si prevede che raggiungerà i 21,57 miliardi entro il 2029, crescendo a un CAGR del 9,4% dal 2022 al 2029
Lo sviluppo di vari tipi di farmaci , così come lo studio degli effetti chimici dei farmaci su diverse cellule e tessuti e la determinazione se questi farmaci possono riparare o sostituire cellule o tessuti danneggiati, vengono tutti eseguiti utilizzando cellule staminali, che vengono ottenute da cellule del sangue o frammenti di midollo osseo. Questo è un mercato che sta emergendo e che è di tendenza.
| ATTRIBUTO | DETTAGLI |
| Periodo di studio | 2022-2029 |
| Anno base | 2021 |
| Anno stimato | 2022 |
| Anno previsto | 2022-2029 |
| Periodo storico | 2018-2020 |
| Unità | Valore (miliardi di USD) |
| Segmentazione | Per prodotto, per applicazione, per utente finale e per regione. |
| Per Prodotto |
|
| Per applicazione |
|
| Da utente finale |
|
| Per regione |
|
Le cellule staminali sono essenziali per la gestione delle malattie e per progetti di ricerca specializzati come test genetici e terapia personalizzata. Gli stakeholder pubblici e aziendali stanno finanziando sempre di più lo sviluppo della tecnologia basata sulle cellule staminali, poiché diventano più consapevoli del potenziale terapeutico delle cellule staminali e della scarsità di trattamenti efficaci per le malattie rare.
La crescente popolazione anziana e l'aumento dell'incidenza del cancro avranno un impatto significativo sullo sviluppo del settore della produzione di cellule staminali . I fattori che stimolano l'espansione del mercato della produzione di cellule staminali includono, oltre a questo, una maggiore urbanizzazione e un reddito personale disponibile. Inoltre, la crescente spesa per le infrastrutture sanitarie è uno dei fattori chiave del settore che spingerebbe ulteriormente il mercato della produzione di cellule staminali. Inoltre, il ritmo di crescita del mercato sarà moderato dalla crescente consapevolezza pubblica dell'efficacia terapeutica dei prodotti a base di cellule staminali.
The global Stem Cell Manufacturing market was valued at 12.58 billion in 2022 and is projected to reach 21.57 billion by 2029, growing at a CAGR of 9.4% from 2022 to 2029
Based on product, application, end-user, and region the stem cell manufacturing market report's divisions are broken down.
The global Stem Cell Manufacturing market registered a CAGR of 9.4% from 2022 to 2029. The industry segment was the highest revenue contributor to the market.
Key players profiled in the report include Thermo Fisher Scientific, Merck Millipore, Lonza Group AG, Danaher Corporation, Sartorius AG, Bio-Rad Laboratories, Becton, Dickinson and Company, Stemcell Technologies, Fujifilm Holdings Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Bio-Techne Corporation, Takara Bio Group, Eppendorf AG, Getinge, Himedia Laboratories, Anterogen, Cellgenix GMBH, and Promocell.
The stem cell manufacturing market was dominated by North America in 2020, followed by Europe. The development of the stem cell manufacturing market in North America is also supported by elements like the region's strong research infrastructure, growing public awareness regarding the therapeutic potential of stem cells in efficient disease management, and rising adoption of novel stem cell therapies in the US.
Based on product, application, end user and region, the global market for professional Stem Cell Manufacturing is divided into these categories.
Consumables, instruments, and stem cell lines make up the market segments for stem cell manufacturing according to the product. The market for stem cell production has a section called stem cell lines that is expanding at the quickest rate. The demand for functionally potent stem cell lines in research, the increasing acceptance of stem cell-based medicinal products in the US, Europe, and Asia, and the development of novel stem cell culture & preservation techniques are the primary drivers of market expansion.
In terms of application, the clinical applications sector held the second-largest market share for stem cell production in 2020.
The stem cell manufacturing market is divided into three application categories based on use: research, clinical, and cell & tissue banking. The growing understanding of stem cells' therapeutic potential in the management of effective disease, technological developments in genome-based cell analysis and other stem cell manufacturing techniques and improving infrastructure for stem cell processing and preservation are the main drivers of the demand for stem cell-based products in clinical applications.
In terms of end users, pharmaceutical and biotechnology firms held the greatest market share for stem cell production in 2020.
The pharmaceutical and biotechnology industries, academic institutions, research laboratories, and contract research organizations, hospitals and surgical centers, cell banks and tissue banks, and other end users are the market segments for stem cell manufacturing based on end users. In 2020, the pharmaceutical and biotechnology industries predominated. Major end customers of stem cell products include pharmaceutical and biotechnology firms. For internal clinical research and medication discovery activities, these goods are used. Stem cell-based research is receiving more private funding, which is what is essentially driving the demand for stem cell products among pharma-biotech businesses.
[caption id="attachment_16526" align="aligncenter" width="1920"]
The major players operating in the global Stem Cell Manufacturing industry include the major market players include Thermo Fisher Scientific, Merck Millipore, Lonza Group AG, Danaher Corporation, Sartorius AG, Bio-Rad Laboratories, Becton, Dickinson and Company, Stemcell Technologies, Fujifilm Holdings Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Bio-Techne Corporation, Takara Bio Group, Eppendorf AG, Getinge, Himedia Laboratories, Anterogen, Cellgenix GMBH, and Promocell.
Industry Development
20 April 2022: The PPD clinical research business of Thermo Fisher Scientific Inc. and Matrix Clinical Trials, a Matrix Medical Network offering, are collaborating to bring clinical trials to patients with an innovative decentralized clinical trial (DCT) solution. 23 January 2023: Two global leaders are joining strengths in a broad new effort to advance the discovery and innovation needed to address complex scientific challenges. The University of California San Diego and Thermo Fisher Scientific have agreed to form a transformational 10-year strategic partnership that leverages the leading expertise of each organization.Geographically, the Stem Cell Manufacturing market is segmented into North America, South America, Europe, APAC, and MEA.
The stem cell manufacturing market was dominated by North America in 2020, followed by Europe. The development of the stem cell manufacturing market in North America is also supported by elements like the region's strong research infrastructure, growing public awareness regarding the therapeutic potential of stem cells in efficient disease management, and rising adoption of novel stem cell therapies in the US. However, this industry is being constrained by strict rules governing ESCs and iPSC-based clinical research as well as fierce market competition from other therapeutic technologies (including gene therapy, drug-based treatment, and tissue and organ transplantation).
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.